Johnson & Johnson
Close on Nov 3, 2026Market cap $641.44BP/E 40.4Yield 1.93%
Johnson & Johnson Other Pulmonary Hypertension medicines by Year
Other Pulmonary Hypertension medicines — Worldwide operational (constant-currency) growth YoY (%) (%)
Johnson & Johnson Other Pulmonary Hypertension medicines: -13.0% in FY2025, down 31.3 pts from a year earlier.
Where the FY2025 figure comes from
“|| WW | 209 | 240 | (12.7) | (13.0) | 0.3”
Source: Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Reported in Form 8-K EX-99.2 Segment Sales Schedule.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Pulmonary Hypertension medicines — Worldwide operational (constant-currency) growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | -13.0% | -31.3 pts | Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗ |
| FY2024 | Dec 29, 2024 | 18.3% | +30.3 pts | Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗ |
| FY2023 | Dec 31, 2023 | -12.0% | +1.1 pts | Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗ |
| FY2022 | Jan 1, 2023 | -13.1% | -8.4 pts | Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗ |
| FY2021 | Jan 2, 2022 | -4.7% | +8.2 pts | Form 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗ |
| FY2020 | Jan 3, 2021 | -12.9% | – | Form 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗ |
Breakdown
What makes up other Pulmonary Hypertension medicines
Cite this data
StockData. (2026). Johnson & Johnson Other Pulmonary Hypertension medicines (%), annual FY2020–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-other-ph-ops-yoy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.
See a number that looks wrong?